Silverfin false false 31/03/2024 01/04/2023 31/03/2024 Mr S L McDermott Dr M R Snaith 05/04/2013 Dr C Thornton 05/04/2013 18 October 2024 The principal activity of the Company during the financial year was the development of diagnostic equipment for use in the health care sector. 08010751 2024-03-31 08010751 bus:Director2 2024-03-31 08010751 bus:Director3 2024-03-31 08010751 2023-03-31 08010751 core:CurrentFinancialInstruments 2024-03-31 08010751 core:CurrentFinancialInstruments 2023-03-31 08010751 core:Non-currentFinancialInstruments 2024-03-31 08010751 core:Non-currentFinancialInstruments 2023-03-31 08010751 core:ShareCapital 2024-03-31 08010751 core:ShareCapital 2023-03-31 08010751 core:SharePremium 2024-03-31 08010751 core:SharePremium 2023-03-31 08010751 core:RetainedEarningsAccumulatedLosses 2024-03-31 08010751 core:RetainedEarningsAccumulatedLosses 2023-03-31 08010751 core:PatentsTrademarksLicencesConcessionsSimilar 2023-03-31 08010751 core:PatentsTrademarksLicencesConcessionsSimilar 2024-03-31 08010751 core:OtherPropertyPlantEquipment 2023-03-31 08010751 core:OtherPropertyPlantEquipment 2024-03-31 08010751 bus:OrdinaryShareClass1 2024-03-31 08010751 bus:OrdinaryShareClass2 2024-03-31 08010751 2023-04-01 2024-03-31 08010751 bus:FilletedAccounts 2023-04-01 2024-03-31 08010751 bus:SmallEntities 2023-04-01 2024-03-31 08010751 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 08010751 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 08010751 bus:Director1 2023-04-01 2024-03-31 08010751 bus:Director2 2023-04-01 2024-03-31 08010751 bus:Director3 2023-04-01 2024-03-31 08010751 core:PatentsTrademarksLicencesConcessionsSimilar core:BottomRangeValue 2023-04-01 2024-03-31 08010751 core:PatentsTrademarksLicencesConcessionsSimilar core:TopRangeValue 2023-04-01 2024-03-31 08010751 core:OtherPropertyPlantEquipment core:TopRangeValue 2023-04-01 2024-03-31 08010751 2022-04-01 2023-03-31 08010751 core:PatentsTrademarksLicencesConcessionsSimilar 2023-04-01 2024-03-31 08010751 core:OtherPropertyPlantEquipment 2023-04-01 2024-03-31 08010751 core:Non-currentFinancialInstruments 2023-04-01 2024-03-31 08010751 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 08010751 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 08010751 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 08010751 bus:OrdinaryShareClass2 2022-04-01 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 08010751 (England and Wales)

ISCA DIAGNOSTICS LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2024
Pages for filing with the registrar

ISCA DIAGNOSTICS LIMITED

Unaudited Financial Statements

For the financial year ended 31 March 2024

Contents

ISCA DIAGNOSTICS LIMITED

BALANCE SHEET

As at 31 March 2024
ISCA DIAGNOSTICS LIMITED

BALANCE SHEET (continued)

As at 31 March 2024
Note 2024 2023
£ £
Fixed assets
Intangible assets 3 9,316 10,452
Tangible assets 4 5,483 8,203
14,799 18,655
Current assets
Debtors 5 42,619 44,331
Cash at bank and in hand 6 33,100 27,582
75,719 71,913
Creditors: amounts falling due within one year 7 ( 10,107) ( 17,559)
Net current assets 65,612 54,354
Total assets less current liabilities 80,411 73,009
Creditors: amounts falling due after more than one year 8 ( 3,657) ( 6,549)
Net assets 76,754 66,460
Capital and reserves
Called-up share capital 9 10,000 10,000
Share premium account 81,600 81,600
Profit and loss account ( 14,846 ) ( 25,140 )
Total shareholders' funds 76,754 66,460

For the financial year ending 31 March 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Isca Diagnostics Limited (registered number: 08010751) were approved and authorised for issue by the Board of Directors on 18 October 2024. They were signed on its behalf by:

Dr C Thornton
Director
ISCA DIAGNOSTICS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2024
ISCA DIAGNOSTICS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Isca Diagnostics Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Lowin House, Tregolls Road, Truro, TR1 2NA, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when the amount of revenue can be reliably measured and it is probable that future economic benefits will flow to the entity.

Employee benefits

Defined contribution schemes
A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Taxation

Current tax
Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Deferred tax
Deferred tax is recognised on all timing differences at the balance sheet date unless indicated below. Timing differences are differences between taxable profits and the results as stated in the profit and loss account and other comprehensive income. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Trademarks, patents and licences 0 - 10 years straight line
Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line basis over its expected useful life, as follows:

Plant and machinery etc. 20 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Financial instruments

The company holds the following financial instruments:

•Short term trade and other debtors and creditors; and
•Cash and bank balances.

All financial instruments are classified as basic.

The company has chosen to apply the recognition and measurement principles in FRS102.

Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument and derecognised when in the case of assets, the contractual rights to cash flows from the assets expire or substantially all the risks and rewards of ownership are transferred to another party, or in the case of liabilities, when the company’s obligations are discharged, expire or are cancelled.

Except for bank loans, such instruments are initially measured at transaction price, including transaction costs, and are subsequently carried at the undiscounted amount of the cash or other consideration expected to be paid or received, after taking account of impairment adjustments.

Bank loans are initially measured at transaction price, including transaction costs, and are subsequently carried at amortised cost using the effective interest method.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 1

3. Intangible assets

Trademarks, patents
and licences
Total
£ £
Cost
At 01 April 2023 13,860 13,860
At 31 March 2024 13,860 13,860
Accumulated amortisation
At 01 April 2023 3,408 3,408
Charge for the financial year 1,136 1,136
At 31 March 2024 4,544 4,544
Net book value
At 31 March 2024 9,316 9,316
At 31 March 2023 10,452 10,452

4. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 01 April 2023 13,598 13,598
At 31 March 2024 13,598 13,598
Accumulated depreciation
At 01 April 2023 5,395 5,395
Charge for the financial year 2,720 2,720
At 31 March 2024 8,115 8,115
Net book value
At 31 March 2024 5,483 5,483
At 31 March 2023 8,203 8,203

5. Debtors

2024 2023
£ £
Trade debtors 0 301
Deferred tax asset 6,363 3,687
Other debtors 36,256 40,343
42,619 44,331

6. Cash and cash equivalents

2024 2023
£ £
Cash at bank and in hand 33,100 27,582

7. Creditors: amounts falling due within one year

2024 2023
£ £
Bank loans 2,395 3,203
Trade creditors 0 1,443
Other taxation and social security 397 209
Other creditors 7,315 12,704
10,107 17,559

8. Creditors: amounts falling due after more than one year

2024 2023
£ £
Bank loans 3,657 6,549

There are no amounts included above in respect of which any security has been given by the small entity.

9. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
6,600 Ordinary shares of £ 1.00 each 6,600 6,600
3,400 Ord ordinary shares of £ 1.00 each 3,400 3,400
10,000 10,000